Please login to the form below

Not currently logged in
Email:
Password:

Almirall launches story campaign to raise rosacea awareness

The Red Girl highlights the negative psychological effects of the disease

Shared Skin

Almirall has launched a new story-based campaign to raise awareness of chronic dermatological disease rosacea in the US.

The Barcelona-based pharmaceutical company’s The Red Girl tells a tale of an embarrassed woman sending an apologetic email to her date.

As the story develops the woman explains she felt embarrassed that her condition flared up during their date, prompting her to leave without warning.

Although the cause is still unknown, rosacea affects around 16 million people in the US alone and is found to be more common in women than men.

The condition can cause redness and pimples typically on the face and neck. Additionally, flare-ups can worsen over time and the skin may adopt a roughened, orange peel texture.

As a ‘less well known disease’, Almirall aims to expose the negative psychological effects rosacea has on an individual by launching The Red Girl as part of its Derma Stories and #SharedSkin initiative.

The #SharedSkin campaign features 5 Almirall employees – one of which appears to have the symptoms of rosacea – with fake skin conditions to show the social impact of living with a dermatological disease.

Almirall said rosacea has “profound effects on a person’s psychological health” and due to its “highly visible nature it takes a particularly heavy toll on patients as there is no cure”.

After acquiring Poli Group in 2015, Almirall obtained a dermatology focused R&D structure including its rosacea brand.

Rosacea has also held a strong focus with various other pharmaceutical companies, among them Omega Pharma and Galderma, and work by both was highlighted at the 2015 Communiqué Awards.

Article by
Gemma Jones

30th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics